FUJIFILM Biotechnologies Expands Strategic Partnership with argenx to Include U.S. Manufacturing Operations

URLhttps://www.businesswire.com/news/home/20250918378
SourceBusiness Wire
Date Published09/18/2025

Additional Reshoring Information:

Company/Division name FUJIFILM Biotechnologies with argenx SE
Parent companyFUJIFILM Holdings Corporation
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2025
Year reshoring implemented or to be implemented:2028
Domestically, the work will be done:In-house
Country(ies) from which reshored:Japan
City reshored to: Holly Springs
State(s) reshored to:SC
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredBiopharmaceuticals; Efgartigimod
What domestic positive factors made reshoring more attractive?Eco-system synergies, Proximity to customers/market
Find Reshoring Articles